Yaz Bellwether Trials Postponed

Judge David Herndon has postponed Yaz bellwether trials, set to take place earlier this month, in favor of a mediation process that will hopefully allow plaintiffs and defendants to come to a settlement agreement outside of court. The mediation will begin "without delay" and overseeing the discussion will be Professor Stephen Saltzburg of George Washington School of Law. 

Protective order granted in Yaz lawsuit

Plaintiff Kerry Sims was going to be the first Yaz plaintiff to see her case in court. The first bellwether trial was set to be Sims v. Bayer et al. Sims, not unlike many other Yaz plaintiffs, has linked her acute left-sided pulmonary embolism, which was diagnosed on the 18th of July 2008, to her Yaz use. Yaz pulmonary embolism is a condition in which a blood clot becomes lodged in one of the lungs' major arteries. It is a condition that may result from Yaz deep vein thrombosis. 

Yaz Bellwether Trials on Hold for Mediation

The preliminary bellwether trials for Yaz side effects were scheduled to begin on January 9, 2012, but they have been put on hold as thousands of Yaz side effects lawsuits have been ordered into mediation by Chief Judge David R. Herndon, who is presiding over the Yaz multidistrict litigation case. The order came down on the 31st of December, 2011, and now instead of each lawsuit going to trial they will now pursue settlements through mediation. 

The move was echoed the consolidated Pennsylvania state court side effects lawsuits, as Judge Sandra Mazer Moss ordered the parties into mediation on the 6th of January, 2012. Yaz side effects lawsuits, which deal with such serious conditions as Yaz pulmonary embolism, Yaz blood clot, and Yaz stroke, will be put on hold as the possibility of a global settlement is explored involving thousands of plaintiffs and the defendant, Bayer pharmaceuticals. 

Mediation Over Trial in Yaz MDL

The mulditistrict litigation case involving Yaz birth control has been consolidated in the Southern District of Illinois and is being presided over by Judge David R. Herndon. Now, this judge has decided to go forward with mediation as opposed to a trial for the first Yaz case out of the many that are involved in the litigation. Thousands of cases are involved in the multi district litigation, filed by women who have experienced side effects associated with Yaz and Yasmin birth control medication. 

According to some reports, Yaz is the fourth most popular birth control pill in the United States, although it is one of those with the most Yaz side effects. Thousands of plaintiffs have become involved in litigation against Bayer Pharmaceuticals, holding them accountable for Yaz and Yasmin side effects. Yaz blood clots, stroke, heart attack, Yaz deep vein thrombosis, and pulmonary embolism have all been cited in Yaz birth control lawsuits.

Yaz and Yasmin Have Few Differences Despite Differences

Both Yasmin and Yaz are produced by Bayer healthcare and are currently known as fourth generation birth control pills. Unfortunately, there has been a lot of discussion on the side effects produced by both the medications. While Yasmin has been found to produce side effects like Yaz gallbladder disease, blood clots in the legs etc, the side effects from Yaz have been reported to be more severe in nature. Yaz lawsuits, Yasmin lawsuits and Ocella lawsuits are being reviewed throughout the United States for women who have suffered serious and potentially life-threatening blood clots, including a deep vein thrombosis (Yaz DVT), which forms in the deep veins of the legs, pelvis or arms.

A DVT or deep vein thrombosis is a type of blood clot that usually occurs in the legs or deep veins of the pelvis.  While it is possible to have a DVT with minimal symptoms, they usually cause extreme pain and swelling in the affected limb.  If the Yaz Deep Vein Thrombosis dislodges, it could travel to other parts of the body and cause a pulmonary emolism, heart attack or stroke.According to an August 2009 study published in the British Medical Journal,

Women Seek Yaz Damages from Bayer for Misleading Advertisements

Every Yaz birth control suits involve allegations that Bayer failed to properly research their birth control pills or adequately warn about the increased risk of serious and potentially life-threatening injuries from the birth control pills containing drospirenone, such as a Yaz Stroke, heart attack, Yaz pulmonary embolism, deep vein thrombosis or gallbladder disease.Yaz and Yasmin were both brought to market by Berlex Labs. Yaz came on the market in 2001, and Yasmin followed five years later. In 2006, Berlex was acquired by Bayer. Backed by big marketing campaigns, it wasn’t long before both drugs were racking up big sales for Bayer. Annual sales of Yaz reached $361 last year. Annual sales of Yasmin peaked in 2008 at $329 million, but have declined somewhat since then.

According to lawsuits filed against Bayer, the makers of Yaz and Yasmin knew or should have known about the risk of Yaz gallbladder disease complications associated with their birth control pill, yet failed to adequately warn about the problems.

Yasmin Gallbladder Disease Has Florida Women Suing For Damages

Alethia M. Lopez and Jessica A. Endick of Tampa, Florida added their lawsuits to the growing case against Bayer’s birthcontrol pills, Yaz and Yasmin. On October 3rd, both women filed suits seeking compensatory damages of $75,000 to pay for gallbladder removal surgery as well as punitive damages. In addition to Yaz gallbladder disease, in August of 2009, The British Medical Journal published the results of two independent studies conducted on women in Denmark and The Netherlands. Both of these studies reached the conclusion that women taking the progestin drospirenone found in Yaz and Yasmin were at a higher risk for venous Yaz blood clots.

Over 50 deaths have been reported to the FDA in women taking oral contraceptives containing drosprienone such as Yaz, Yasmin or Ocella from heart problems, heart attacks, blood clots in the heart and lungs, and Yaz Stroke.  In addition, the Agency has received hundreds of reports of non-fatal side effects from these conditions.

Plaintiffs Questioning Potential Settlement Amounts in Yaz Lawsuits

As of February 2011, Bayer faced nearly 7,000 lawsuits against their Yaz and Yasmin birth control pills and the number of new claims is continuing to grow. It is anticipated that to resolve the litigation, the pharmaceutical company will ultimately need to reach Yaz settlements and Yasmin settlements with up to 25,000 women.Currently the Yasmin and Yaz lawsuit have been centralized for pretrial proceedings in the federal court system as well as several states. In federal court, all cases filed throughout the country are being handled out of the U.S. District Court for the Southern District of Illinois for coordinated management during discovery, the early bellwether trials and any preliminary attempts to negotiate settlement offers. Similar centralized management for the cases has been put in place for state court cases filed in New Jersey and Pennsylvania.

All of the cases involve similar allegations that Bayer failed to adequately warn about the risk of serious and potentially life-threatening side effects of Yaz and Yasmin birth control, such as a stroke pulmonary embolism, deep vein thrombosis or Yaz gallbladder disease. Plaintiffs’ attorneys recently asked Judge Herndon to consolidate several cases for the second and third trials,

Woman Files Northern California Yaz Lawsuit

A growing number of Yasmin lawsuits and Yaz class action lawsuit have been filed over alleged side effects of the birth control pills, which may increase the risk of heart attack, stroke, deep vein thrombosis, (DVT), pulmonary embolysm (PE), Yaz gallbladder disease, death and other serious injuries. Another lawsuit has been filed against Bayer Pharmaceuticals over Yasmin injuries. Louise Thanos says she took Yasmin, which is manufactured by Bayer Pharmaceuticals, from November 20007 to November 2009, and alleges she suffered from organ failure as a result of the pills. Thanos also alleges that, in March 2008, she suffered from gallbladder failure, according to the lawsuit filed in San Mateo County Superior Court.

Yaz and Yasmin are both made with a type of progestin called drospirenone, making them different from many other oral contraceptives. Drospirenone can elevate the body’s potassium levels, which can lead to a condition called hyperkalemia in certain patients. Hyperkalemia may result in potentially serious heart and health problems. Adverse Events reported to the U.S. Food & Drug Administration (FDA) involving Yaz and Yasmin include heart arrhythmias, electrolyte imbalance, hyperkalemia, atrial fibrillation, tachycardia, myocardial infarction, stroke, blood clots, Yaz pulmonary embolism, and sudden death.The drug makers had sole access to facts concerning the potential Yaz problems, and ignored the correlation between their drug and potentially life-threatening side effects. 

Yaz Pulmonary Embolism Lawsuits on the Rise

Yaz birth control, despite the many controversies surrounding it, continues to be one of the most popular forms of hormonal birth control used across the country. Women continue to experience severe cardiovascular Yaz side effects from the drospirenone-based fourth generation birth control pill, but more and more people – especially teenagers and young women – continue to use the potentially dangerous medication on a regular basis, despite the growing number of Yaz lawsuit directed towards its drugmaker, Bayer Pharmaceuticals.

Pulmonary embolism, deep vein thrombosis, and cor pulmonale are all conditions that can develop from blood clots, depending where they are located in the body. Yaz Deep Vein Thrombosis occurs when a blood clot forms in a vein deep in the body, usually in the leg. Blood clots here can travel through the body to block an artery to the lung and potentially cause pulmonary embolism.

Yaz Pulmonary Embolism Among First on Trial

Bellwether trials in the ongoing Yaz and Yasmin litigation cases are slowly making their way towards their first day, and among the first cases on trial will involve the deadly Yaz pulmonary embolism. A pulmonary embolism takes place when a Yaz blood clots makes its way to one of the arteries in the lung. One in three people who experience pulmonary embolism do not survive it, and as such it is one of the deadliest killers in the country. The Food and Drug Administration is expected to issue a report on Yaz pulmonary embolism as associated with Yaz and Yasmin by the end of the year.

Even young women are at risk for severe Yaz side effects, and the birth control remains a popular one for teenage girls and young adults. Although there is some risk of blood clots with any hormonal birth control medication,

Yaz Pulmonary Embolism Accusers Filing

Bayer, the manufacturer of popular fourth-generation birth control pill Yaz, are facing a slew of lawsuits that have been plaguing them for years already. Yaz lawsuit allege that Yaz has caused a number of patients serious pain, emotional trauma, and other complications that could last for the rest of their lives. Yaz has been linked to a number of serious medical conditions, some of them fatal, many of which relate in some way to blood clots forming and possibly breaking off from the vein in which they were formed. 

Yaz pulmonary embolism is one of the most serious conditions represented by Yaz lawsuits—and one of the most common. Other side effects alleged in lawsuits include heart arrhythmia, Yaz Stroke, blood clots like deep vein thrombosis, and Yaz gallbladder disease. It occurs when a blood clot forms in an extremity such as the leg, then breaks off and travels through the bloodstream to block one of the main arteries in the lung.

Yaz Stroke Hurts the Healthy

Even otherwise healthy women can find themselves experiencing blood clots, stroke, heart arrhythmia, gallbladder disease, and pulmonary embolism—especially if they take the popular fourth-generation birth control marketed as Yaz or Yasmin. Both of these medications are based around a synthetic hormone called drospirenone, which science thinks could be the culprit behind the raised risk of Yaz blood clots problems and other issues with the birth control pill. And there are some issues—Yaz users are up to six times more likely to experience problems with blood clots and other Yaz side effects than women who take other forms of hormonal birth control. This is while taking into account the fact that all hormonal birth control, whether it be in pill, patch, or ring form, comes with some heightened risk of blood clots.

Almost 6,000 cases have been filed across the country regarding serious side effects such as Yaz Stroke and pulmonary embolism. These side effects can be fatal—and have proven to be in a number of cases.